Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vesicle-trafficking protein SEC22a (SEC22A) is a SNARE protein that facilitates the transport of vesicles between the ER and Golgi, an essential process for protein sorting, secretion, and cellular homeostasis[1][2][4][5]. SEC22A forms part of the multiprotein SNARE complex, promoting membrane fusion events both in the secretory pathway and in autophagic processes[1]. Its functions ensure the correct trafficking and localization of newly synthesized proteins within the cell. Mutations or dysfunctions in SEC22A or its homologs can result in diseases such as neurodegeneration (e.g., Alzheimer's disease), Warburg Micro syndrome, and atherosclerosis, largely due to impaired protein and lipid transport mechanisms[1][5]. Although critical for cell physiology, SEC22A is not a direct pharmacological target but may be of interest in studies of membrane trafficking, cell biology, and certain rare genetic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicle-trafficking protein SEC22a (SEC22A).